COMMUNIQUÉS West-GlobeNewswire

Surface Oncology Announces Closing of $119.5 Million Aggregate Financing, Consisting of $108.0 Million Initial Public Offering and $11.5 Million Concurrent Private Placement
23/04/2018
CAMBRIDGE, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Surface Oncology, Inc. (“Surface”), an immuno-oncology company developing next-generation antibody therapies that target the tumor microenvironment, today announced [...]
Brian Andrews to Succeed Albert White as Chief Financial Officer of The Cooper Companies
23/04/2018
PLEASANTON, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) today announced that Brian Andrews has been promoted to Senior Vice President, Chief Financial Officer and Treasurer of The [...]
Natus Confirms Receipt of Notice of Voce Capital’s Intent to Nominate Director Candidates to Replace 50% of the Natus Board
23/04/2018
No Shareholder Action Required at this Time PLEASANTON, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) (“Natus” or the “Company”) today confirmed that Voce Capital Management LLC [...]
Genesis HealthCare Sells 51% Stake in Chinese Subsidiary GRS-HS to Riswein Health Industry Investment Co., Ltd
23/04/2018
KENNETT SQUARE, Pa., April 23, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare (Genesis, or the Company) (NYSE: GEN ), one of the largest post-acute care providers in the United States, today announced that it has signed a [...]
Harvard Bioscience Schedules First Quarter 2018 Conference Call for May 2 at 4:30 PM ET
23/04/2018
HOLLISTON, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO ), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results [...]
ChromaDex Appoints Frank Jaksch As Executive Chairman, Rob Fried as Chief Executive Officer and Kurt Gustafson as Lead Director
23/04/2018
New Management Structure Further Fuels Strategic Evolution into Consumer-Focused Integrated Nutraceutical Company IRVINE, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ: CDXC ), an integrated, [...]
Tivity Health Reports First-Quarter 2018 Results and Affirms Financial Guidance
23/04/2018
REVENUES OF $150 MILLION AND DILUTED EPS OF $0.49 ANNOUNCES HIRING OF CHIEF BRAND OFFICER NASHVILLE, Tenn., April 23, 2018 (GLOBE NEWSWIRE) -- Tivity Health, Inc. (NASDAQ: TVTY ) today announced financial results for [...]
Avadim Technologies Receives Notices of Allowance From U.S. and Japan Patent Offices for Inventions Related to Reducing Catheter Associated Urinary Tract Infections (CAUTI)
23/04/2018
ASHEVILLE, N.C., April 23, 2018 (GLOBE NEWSWIRE) -- Avadim Technologies, Inc. (“Avadim”), the Bionome Therapies TM life sciences company, announced today that its patent applications have been allowed in the U.S. and [...]
Adventist Health and St. Joseph Health Announce Formation of a New Joint Operating Company
23/04/2018
Affiliation will expand access to quality care in Humboldt, Mendocino, Lake, Sonoma, Napa and Solano counties SANTA ROSA, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Adventist Health and St. Joseph Health announced an [...]
Optinose CEO Peter Miller and President/COO Ramy Mahmoud Named EY Entrepreneur of the Year 2018 Finalists in the Greater Philadelphia Area
23/04/2018
YARDLEY, Pa., April 23, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN ), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that CEO Peter [...]
Nuvectra™ to Report First Quarter 2018 Financial Results on May 2, 2018
23/04/2018
PLANO, Texas, April 23, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, announced today that it will release its financial results for the first quarter ended [...]
Nohla Therapeutics Announces Hiring of Gary Christianson as Chief Operating Officer
23/04/2018
Mr. Christianson Brings More Than 30 Years of Commercial and Operational Expertise SEATTLE, April 23, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a clinical stage biopharmaceutical company focused on the [...]
Probiodrug Appoints Dr. Ulrich Dauer as Chief Executive Officer
23/04/2018
Probiodrug Appoints Dr. Ulrich Dauer as Chief Executive Officer Dr. Ulrich Dauer to team up with Chief Development Officer, Dr. Inge Lues, effective May 1, 2018; Dr. Konrad Glund and Dr. Hendrik Liebers to continue in [...]
Samumed’s Osteoarthritis and Tendinopathy Research Selected for Multiple Presentations at the 2018 Osteoarthritis Research Society International (OARSI) World Congress
23/04/2018
SAN DIEGO, April 23, 2018 (GLOBE NEWSWIRE) -- Samumed, LLC, a leader in Wnt research and development, today announced it will present its most recent clinical and preclinical data on the company’s investigational Wnt [...]
Title21 Health Solutions Honored as a ‘Best Place to Work’ for the Second Year in a Row
23/04/2018
Enterprise Healthcare Technology Company, Title21 Health Solutions, was Voted a ‘Best Place to Work’ by the San Francisco Business Times PLEASANTON, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Title21 Health Solutions, “ [...]
Summit Therapeutics plc : Director/PDMR Shareholding
23/04/2018
Summit Therapeutics plc ('Summit' or the 'Company') Exercise of Share Options Oxford, UK, and Cambridge, MA, US, 23 April 2018 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), announces the exercise by the following [...]
Ossur Hf : Transactions in relation to share buyback program
23/04/2018
Announcement no. 30/2018 Reykjavik, 23 April 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]
OSE Immunotherapeutics Receives the EuroNext Tech40 Label
23/04/2018
NANTES, France, April 23, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN: FR0012127173) (Mnémo:OSE) has received the EuroNext Tech40 Label and is thus admitted to the “Tech40” index. Wanting to give more [...]
Diaxonhit, acteur incontournable du diagnostic in vitro et des sciences de la vie: Résultats annuels 2017
23/04/2018
Résultats annuels 2017 Un nouveau Groupe Acteur incontournable du diagnostic in vitro et des sciences de la vie EBITDA retraité [1] pro forma positif à +0,4 M€ pour l'ensemble de l'exercice 2017, dépassant l'objectif [...]

Pages